FindTrial
Sign In

Safety and efficacy of perioperative VTE prophylactic anticoagulant therapy in hip fractures: a multicenter real-world study

Safety and efficacy of perioperative VTE prophylactic anticoagulant therapy in hip fractures: a multicenter real-world study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075245
Enrollment
Unknown
Registered
2023-08-30
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

Hip fracture patients:None

Sponsors

The Third Hospital of Mianyang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: Patients admitted for surgical treatment for hip fractures (intertrochanteric, neck, and subtrochanteric)

Exclusion criteria

Exclusion criteria: ? Patients with VTE before hip fracture injury; ? Patients who did not undergo lower extremity venous color ultrasound or angiography to determine whether there is thrombosis; ? Patients with unclear or no records of thrombosis prevention; ? Important data loss.

Design outcomes

Primary

MeasureTime frame
anticoagulant therapy;Thrombosis;Bleeding event;—

Countries

CHINA

Contacts

Public ContactZhang Shaoyun

The Third Hospital of Mianyang

zhangsyhm2068@163.com+86 199 5081 1015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026